DPYD and Hand-foot syndrome: Patients on DPD inhibitor-associated fluoropyrimidine treatments, such as uracil/tegafur or S-1, only occasionally experience HFS, which suggests that this adverse event is caused by the metabolites of 5-FU (Yen-Revollo et al., 2008).